| 000 | 01328 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250516034457.0 | ||
| 264 | 0 | _c20110809 | |
| 008 | 201108s 0 0 eng d | ||
| 022 | _a1098-4275 | ||
| 024 | 7 |
_a10.1542/peds.2010-1928 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKnops, Noël B B | |
| 245 | 0 | 0 |
_aApparent mineralocorticoid excess: time of manifestation and complications despite treatment. _h[electronic resource] |
| 260 |
_bPediatrics _cJun 2011 |
||
| 300 |
_ae1610-4 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_a11-beta-Hydroxysteroid Dehydrogenase Type 2 _xgenetics |
| 650 | 0 | 4 |
_aDNA _xgenetics |
| 650 | 0 | 4 |
_aDiet, Sodium-Restricted _xmethods |
| 650 | 0 | 4 | _aDietary Supplements |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHomozygote |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aMineralocorticoid Excess Syndrome, Apparent _xdiagnosis |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aPedigree |
| 650 | 0 | 4 |
_aPotassium _xtherapeutic use |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aMonnens, Leo A | |
| 700 | 1 | _aLenders, Jacques W | |
| 700 | 1 | _aLevtchenko, Elena N | |
| 773 | 0 |
_tPediatrics _gvol. 127 _gno. 6 _gp. e1610-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1542/peds.2010-1928 _zAvailable from publisher's website |
| 999 |
_c20800716 _d20800716 |
||